BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16716553)

  • 1. Magnetic resonance imaging for hepatic radiofrequency ablation.
    Clasen S; Boss A; Schmidt D; Fritz J; Schraml C; Claussen CD; Pereira PL
    Eur J Radiol; 2006 Aug; 59(2):140-8. PubMed ID: 16716553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance guidance for radiofrequency ablation of liver tumors.
    Clasen S; Pereira PL
    J Magn Reson Imaging; 2008 Feb; 27(2):421-33. PubMed ID: 18219677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors.
    Clasen S; Boss A; Schmidt D; Schraml C; Fritz J; Schick F; Claussen CD; Pereira PL
    J Magn Reson Imaging; 2007 Oct; 26(4):1043-52. PubMed ID: 17896364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency thermal ablation: the role of MR imaging in guiding and monitoring tumor therapy.
    Nour SG; Lewin JS
    Magn Reson Imaging Clin N Am; 2005 Aug; 13(3):561-81. PubMed ID: 16084420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative magnetic resonance imaging ablation of hepatic tumors.
    Martin RC
    Am J Surg; 2005 Apr; 189(4):388-94. PubMed ID: 15820448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peri-intraprocedural imaging: US, CT, and MRI.
    Crocetti L; Della Pina C; Cioni D; Lencioni R
    Abdom Imaging; 2011 Dec; 36(6):648-60. PubMed ID: 21584636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
    Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
    Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
    Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
    Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of liver cancer.
    Lencioni R; Crocetti L
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of therapeutic effect of liver tumor ablation procedures.
    Bartolozzi C; Crocetti L; Cioni D; Donati FM; Lencioni R
    Hepatogastroenterology; 2001; 48(38):352-8. PubMed ID: 11379308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of the liver: how do we do it.
    Vandenbroucke F; Ilsen B; Craggs B; Op de Beeck B; de Mey J
    JBR-BTR; 2007; 90(6):490-1. PubMed ID: 18376762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time iterative monitoring of radiofrequency ablation tumor therapy with 15O-water PET imaging.
    Bao A; Goins B; Dodd GD; Soundararajan A; Santoyo C; Otto RA; Davis MD; Phillips WT
    J Nucl Med; 2008 Oct; 49(10):1723-9. PubMed ID: 18794264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.
    Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA
    J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VX2 carcinoma in rabbits after radiofrequency ablation: comparison of MR contrast agents for help in differentiating benign periablational enhancement from residual tumor.
    Kim TJ; Moon WK; Cha JH; Goo JM; Lee KH; Kim KH; Lee JW; Han JG; Weinmann HJ; Chang KH
    Radiology; 2005 Feb; 234(2):423-30. PubMed ID: 15591437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous radiofrequency ablation of osteoid osteomas: technique and results].
    Bruners P; Penzkofer T; Günther RW; Mahnken A
    Rofo; 2009 Aug; 181(8):740-7. PubMed ID: 19517335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-based monitoring of magnetic resonance-guided thermoablative therapies for liver tumors.
    Rempp H; Clasen S; Pereira PL
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1281-94. PubMed ID: 21785888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
    Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
    J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic radiofrequency ablation of liver tumors: comparison of MR guidance versus conventional laparoscopic ultrasound for needle positioning in a phantom model.
    Chopra SS; Schmidt SC; Wiltberger G; Denecke T; Streitparth F; Seebauer C; Teichgräber U; Schumacher G; Eisele RM
    Minim Invasive Ther Allied Technol; 2011 Jul; 20(4):212-7. PubMed ID: 21082902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.